PVI
Pura Vida Investments Portfolio holdings
AUM
$16.6M
This Quarter Return
-9.24%
1 Year Return
-3.82%
3 Year Return
-0.02%
5 Year Return
+29.84%
10 Year Return
+256.58%
AUM
$147M
AUM Growth
+$147M
(-12%)
Cap. Flow
+$3.15M
Cap. Flow
% of AUM
2.15%
Top 10 Holdings %
Top 10 Hldgs %
41.99%
Holding
77
New
12
Increased
25
Reduced
11
Closed
11
Top Buys
| 1 |
Abbott
ABT
|
$3.22M |
| 2 |
Boston Scientific
BSX
|
$2.95M |
| 3 |
VAR
Varian Medical Systems, Inc.
VAR
|
$2.95M |
| 4 |
BXLT
BAXALTA INC COM STK (DE)
BXLT
|
$2.52M |
| 5 |
ELGX
Endologix Inc
ELGX
|
$2.52M |
Top Sells
| 1 |
SIEN
Sientra, Inc.
SIEN
|
$5.61M |
| 2 |
Cooper Companies
COO
|
$4.43M |
| 3 |
SPNC
Spectranetics Corp
SPNC
|
$4.28M |
| 4 |
CPHD
Cepheid Inc
CPHD
|
$3.34M |
| 5 |
Biogen
BIIB
|
$2.95M |
Sector Composition
| 1 | Healthcare | 78.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Cigna
CI
$80.3B
| $8.24M | 4.7% | 61,000 -4,000 | -6% | -$540K |
|
2
Universal Health Services
UHS
$11.6B
| $8.09M | 4.62% | 64,800 +4,800 | +8% | +$599K |
|
3
Teleflex
TFX
$5.59B
| $7.14M | 4.08% | 57,500 +8,700 | +18% | +$1.08M |
|
4
Stryker
SYK
$150B
| $7.06M | 4.03% | 75,000 +25,000 | +50% | +$2.35M |
|
|
5
Boston Scientific
BSX
$156B
| $6.81M | 3.89% | 415,000 +180,000 | +77% | +$2.95M |
|
6
Pfizer
PFE
$141B
| $6.12M | 3.49% | 194,875 +52,375 | +37% | +$1.65M |
|
|
NXTM
7
DELISTED
NxStage Medical Inc.
NXTM
| $4.89M | 2.79% | 310,000 +49,800 | +19% | +$785K |
|
8
Insulet
PODD
$23.9B
| $4.68M | 2.67% | 180,600 +80,600 | +81% | +$2.09M |
|
|
WMGI
9
DELISTED
Wright Medical Group Inc
WMGI
| $4.42M | 2.52% | 210,101 +90,000 | +75% | +$1.89M |
|
10
Bausch Health
BHC
$2.74B
| $4.13M | 2.35% | 23,125 +10,625 | +85% | +$1.9M |
|
11
AbbVie
ABBV
$372B
| $4.03M | 2.3% | 74,000 +16,625 | +29% | +$904K |
|
12
Eli Lilly
LLY
$657B
| $3.7M | 2.11% | 44,250 +17,750 | +67% | +$1.49M |
|
|
CYBX
13
DELISTED
CYBERONICS INC
CYBX
| $3.65M | 2.08% | 60,000 | – | – |
|
14
Accuray
ARAY
$157M
| $3.57M | 2.03% | 713,700 +333,700 | +88% | +$1.67M |
|
|
NUVA
15
DELISTED
NuVasive, Inc.
NUVA
| $3.51M | 2% | 72,780 -21,359 | -23% | -$1.03M |
|
|
16
Abbott
ABT
$231B
| $3.22M | 1.84% | +80,000 | New | +$3.22M |
|
17
Bristol-Myers Squibb
BMY
$96B
| $3.18M | 1.82% | 53,750 +3,125 | +6% | +$185K |
|
|
CYNA
18
DELISTED
CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA)
CYNA
| $3.1M | 1.77% | 194,461 | – | – |
|
|
VAR
19
DELISTED
Varian Medical Systems, Inc.
VAR
| $2.95M | 1.68% | +40,000 | New | +$2.95M |
|
20
Vanda Pharmaceuticals
VNDA
$279M
| $2.79M | 1.59% | 247,500 -60,000 | -20% | -$677K |
|
21
Perrigo
PRGO
$3.27B
| $2.75M | 1.57% | 17,500 +375 | +2% | +$59K |
|
|
KITE
22
DELISTED
Kite Pharma, Inc.
KITE
| $2.71M | 1.55% | 48,750 +12,750 | +35% | +$710K |
|
|
BXLT
23
DELISTED
BAXALTA INC COM STK (DE)
BXLT
| $2.52M | 1.44% | +80,000 | New | +$2.52M |
|
|
ELGX
24
DELISTED
Endologix Inc
ELGX
| $2.52M | 1.44% | +205,100 | New | +$2.52M |
|
25
Edwards Lifesciences
EW
$47.8B
| $2.49M | 1.42% | 17,500 -7,500 | -30% | -$1.07M |
|